Outpatient antibiotic therapy administered as a continuous infusion using a pump

Outpatient Parenteral Antibiotic Therapy (OPAT) administered as continuous infusion by elastomeric pumps: Outcomes, pharmacokinetics, patient and staff experiences, and cost

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN13982454

Enrollment

100

Registered

2026-01-26

Start date

2025-06-01

Completion date

Unknown

Last updated

2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antibiotic treatment of infectious diseases, e.g. endocarditis, orthopaedic infections Infections and Infestations

Interventions

Patients will be included in the studies while they are still inpatients receiving antibiotic treatment with standard intermittent dosing. Patients will be recruited from the ID wards or our partner w

Eligibility

Sex/Gender

All

Age

18 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 years or older 2. Treated with intravenous antibiotic therapy for an infection and who need prolonged intravenous treatment, but who do not otherwise need inpatient hospital care 3. All bacterial infections falling in this category 4. Treatments using cloxacillin, piperacillin/tazobactam, vancomycin and benzylpenicillin 5. Patients who consent to participate

Exclusion criteria

Exclusion criteria: 1. Inability to consent to participation for cognitive reasons, such as dementia 2. Insufficient knowledge of Swedish or English in combination with the absence of an authorized interpreter 3. Patients prescribed treatment other than those stated above (as stability for these antibiotics is poor and therefore cannot be given in the 24-hour continuous infusion pumps)

Countries

Sweden

Contacts

Public ContactJaran Eriksen

jaran.eriksen@ki.se+46812361759

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 15, 2026